Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Interventions

netupitant, palosentron drug combination 1 Surveys and Questionnaires 1 Olanzapine 1 NDC80 protein, human 1 Interviews as Topic 1 Immunoenzyme Techniques 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Vomiting × NDC80 protein, human × Clear all

NCT01366599 2017-05-24

CV Events in Emetogenic Chemotherapy

GlaxoSmithKline

12,058 enrolled

Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡